Mayne denies continuous disclosure breaches in feud with Cosette

Mayne denies continuous disclosure breaches in feud with Cosette

Save (1) Please login to bookmarkClose Username or Email Address Password Remember Me Mayne Pharma has denied US drug maker Cosette’s claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger. Subscribe to Lawyerly to access this article.Already a subscriber? Username or Email Address…